Filing Details

Accession Number:
0001415889-23-008417
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-19 16:41:58
Reporting Period:
2023-05-19
Accepted Time:
2023-05-19 16:41:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1211583 Fennec Pharmaceuticals Inc. FENC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1185945 A Chris Rallis C/O Fennec Pharmaceuticals, Inc.
Po Box 13628, 68 Tw Alexander Drive
Research Triangle Park NC 27709
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2023-05-19 833 $7.36 31,958 No 4 S Direct
Common Shares Disposition 2023-05-19 925 $7.36 31,033 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Sale of common shares sold in accordance with 10b5-1 plan. Commom shares resulted from exercise of option grant with grant date of 4/4/2012.
  2. Sale of common shares sold in accordance with 10b5-1 plan. Commom shares resulted from exercise of option grant with grant date of 5/17/2012.